XNASLFST
Market cap2.87bUSD
Dec 27, Last price
7.49USD
1D
0.67%
1Q
7.93%
IPO
-68.79%
Name
Lifestance Health Group Inc
Chart & Performance
P/E
—
P/S
2.71
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
1.06b
+22.82%
Net income
-186m
L-13.59%
CFO
-17m
L
Earnings
Jun 03, 2025
Profile
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
IPO date
Jun 10, 2021
Employees
6,132
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | 1,055,665 22.82% | 859,542 28.77% | 667,511 76.96% | ||
Cost of revenue | 1,164,362 | 1,009,150 | 901,670 | ||
Unusual Expense (Income) | |||||
NOPBT | (108,697) | (149,608) | (234,159) | ||
NOPBT Margin | |||||
Operating Taxes | (20,321) | (17,166) | (25,908) | ||
Tax Rate | |||||
NOPAT | (88,376) | (132,442) | (208,251) | ||
Net income | (186,262) -13.59% | (215,564) -29.83% | (307,197) 706.93% | ||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | (904) | 549,905 | |||
BB yield | 0.05% | -17.64% | |||
| Debt | |||||
Debt current | 49,400 | 38,824 | 1,323 | ||
Long-term debt | 689,474 | 689,075 | 157,416 | ||
Deferred revenue | 123,238 | ||||
Other long-term liabilities | 124,190 | 2,783 | 53,632 | ||
Net debt | 657,119 | 614,852 | 53,266 | ||
| Cash flow | |||||
Cash from operating activities | (16,884) | 52,789 | 9,420 | ||
CAPEX | (40,520) | (79,255) | (94,492) | ||
Cash from investing activities | (60,340) | (139,461) | (194,076) | ||
Cash from financing activities | 47,427 | 47,264 | 313,856 | ||
FCF | (53,681) | (370,758) | (304,695) | ||
| Balance | |||||
Cash | 78,824 | 108,621 | 148,029 | ||
Long term investments | 2,931 | 4,426 | (42,556) | ||
Excess cash | 28,972 | 70,070 | 72,097 | ||
Stockholders' equity | (754,754) | (565,601) | (353,329) | ||
Invested Capital | 2,818,916 | 2,563,596 | 2,110,728 | ||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | 367,457 | 355,278 | 327,523 | ||
Price | 7.83 58.50% | 4.94 -48.11% | 9.52 | ||
Market cap | 2,877,188 63.94% | 1,755,073 -43.71% | 3,118,019 | ||
EV | 3,534,307 | 2,369,925 | 3,171,285 | ||
EBITDA | (28,260) | (80,410) | (180,023) | ||
EV/EBITDA | |||||
Interest | 21,220 | 19,928 | 38,911 | ||
Interest/NOPBT | |||||